Alzheimer's patients continue experimental treatment in Long-Term safety study
NCT ID NCT07228078
Summary
This study continues testing an experimental treatment called SNK01 for Alzheimer's disease to check its long-term safety and see if it might help with thinking and memory. It's for 30 people who already completed an earlier study of the same treatment. Participants receive SNK01 through an IV infusion every three weeks while researchers monitor for side effects and track changes in cognitive tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Behavioral Research Specialists, LLC
RECRUITINGGlendale, California, 91206, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.